Vaccines Global Market Report 2020-30: Covid 19 Impact and Recovery

Home > Market Research Reports > Pharmaceutical

	Market Research Report Vaccines Global Market Report 2020-30: Covid 19 Impact and Recovery
Published by	The Business Research Company			Product code	967596
Published	Pre-Order	Content info	200 Pages Delivery time: Inquiry
Price	PDF (Single User License) USD 4000 PDF (Site License) USD 6000 PDF (Enterprise License) USD 8000

Description

Vaccines Global Market Report 2020-30: Covid 19 Impact and Recovery from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global vaccines market as it emerges from the Covid 19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the vaccines? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Vaccines Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The Market Characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
Market segmentations break down market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered: 1) By Type: Anti-Infective Vaccines; Autoimmunity; Others (Cancer And Others)

2) By Technology: Conjugate Vaccines; Inactivated and Subunit Vaccines; Live Attenuated Vaccines; Recombinant Vaccines; Toxoid Vaccines

3) By Route of Administration: Intramuscular (IM); Subcutaneous (SC); Oral; Others

4) By Valance: Monovalent; Multivalent

5) By Distribution Channel: Institutional Sale; Hospital Pharmacies; Retail Pharmacies

Companies Mentioned: AstraZeneca; Emergent Biosolutions; Glaxosmithkline; Merck; Pfizer

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Vaccines Market Characteristics

3. Vaccines Market Size And Growth

3.1. Global Vaccines Historic Market, 2015-2019, $ Billion
- 3.1.1. Drivers Of The Market
- 3.1.2. Restraints On The Market
3.2. Global Vaccines Forecast Market, 2019-2023F, 2025F, 2030F, $ Billion
- 3.2.1. Drivers Of The Market
- 3.2.2. Restraints On the Market

4. Vaccines Market Segmentation

4.1. Global Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Anti-Infective Vaccines
Autoimmunity
Others (Cancer And Others)
4.2. Global Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Conjugate Vaccines
Inactivated and Subunit Vaccines
Live Attenuated Vaccines
Recombinant Vaccines
Toxoid Vaccines
4.3. Global Vaccines Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Intramuscular (IM)
Subcutaneous (SC)
Oral
Others
4.4. Global Vaccines Market, Segmentation By Valance, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Monovalent
Multivalent
4.5. Global Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Institutional Sale
Hospital Pharmacies
Retail Pharmacies

5. Vaccines Market Regional And Country Analysis

5.1. Global Vaccines Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Vaccines Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Vaccines Market

6.1. Asia-Pacific Vaccines Market Overview
6.2. Asia-Pacific Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Vaccines Market

7.1. China Vaccines Market Overview
7.2. China Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
7.3. China Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Vaccines Market

8.1. India Vaccines Market Overview
8.2. India Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
8.3. India Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Vaccines Market

9.1. Japan Vaccines Market Overview
9.2. Japan Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
9.3. Japan Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Vaccines Market

10.1. Australia Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
10.2. Australia Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Vaccines Market

11.1. Indonesia Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
11.2. Indonesia Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Vaccines Market

12.1. South Korea Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
12.2. South Korea Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Vaccines Market

13.1. Western Europe Vaccines Market Overview
13.2. Western Europe Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
13.3. Western Europe Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Vaccines Market

14.1. UK Vaccines Market Overview
14.2. UK Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
14.3. UK Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Vaccines Market

15.1. Germany Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
15.2. Germany Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Vaccines Market

16.4. France Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
16.5. France Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Vaccines Market

17.1. Eastern Europe Vaccines Market Overview
17.2. Eastern Europe Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Vaccines Market

18.1. Russia Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
18.2. Russia Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Vaccines Market

19.1. North America Vaccines Market Overview
19.2. North America Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
19.3. North America Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Vaccines Market

20.1. USA Vaccines Market Overview
20.2. USA Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
20.3. USA Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Vaccines Market

21.1. South America Vaccines Market Overview
21.2. South America Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
21.3. South America Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Vaccines Market

22.1. Brazil Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
22.2. Brazil Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Vaccines Market

23.1. Middle East Vaccines Market Overview
23.2. Middle East Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
23.3. Middle East Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Vaccines Market

24.1. Africa Vaccines Market Overview
24.2. Africa Vaccines Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
24.3. Africa Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Vaccines Market Competitive Landscape And Company Profiles

25.1. Vaccines Market Competitive Landscape
25.2. Vaccines Market Company Profiles
- 25.2.1. AstraZeneca
  - 25.2.1.1. Overview
  - 25.2.1.2. Products and Services
  - 25.2.1.3. Strategy
  - 25.2.1.4. Financial Performance
- 25.2.2. Emergent Biosolutions
  - 25.2.2.1. Overview
  - 25.2.2.2. Products and Services
  - 25.2.2.3. Strategy
  - 25.2.2.4. Financial Performance
- 25.2.3. Glaxosmithkline
  - 25.2.3.1. Overview
  - 25.2.3.2. Products and Services
  - 25.2.3.3. Strategy
  - 25.2.3.4. Financial Performance
- 25.2.4. Merck
  - 25.2.4.1. Overview
  - 25.2.4.2. Products and Services
  - 25.2.4.3. Strategy
  - 25.2.4.4. Financial Performance
- 25.2.5. Pfizer
  - 25.2.5.1. Overview
  - 25.2.5.2. Products and Services
  - 25.2.5.3. Strategy
  - 25.2.5.4. Financial Performance